Compounds and methods for treating transplant rejection
Details for Australian Patent Application No. 2002363318 (hide)
International Classifications
Event Publications
19 June 2003 Complete Application Filed
Priority application(s): 60/339,535 25.10.01 US
24 July 2003 Application Open to Public Inspection
Published as AU-B-2002363318
11 September 2008 Application Accepted
Published as AU-B-2002363318
22 January 2009 Standard Patent Sealed
26 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002363319-Omega-CYCLOALKYL 17-HETEROARYL PROSTAGLANDIN E2 ANALOGS AS EP2-RECEPTOR AGONISTS
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser